Zetia marketers never fully revealed liver risks: NY Times
December 21 2007
Merck and Schering-Plough conducted several studies of their cholesterol treatment Zetia that raise questions about its risks to the liver ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.